The Latin America, Middle East and Africa Amniotic Products Market should witness market growth of 10.9% CAGR during the forecast period (2023-2030).
A considerable market expansion for amniotic membranes is anticipated over the forecast period due to increased technological advancements aimed at cost-effective therapies. The growth of the elderly population, increased knowledge of the benefits of amniotic membrane transplantation, and increased amniotic membrane transplantation all contribute to the market's expansion. On the other hand, the enormous market potential in developing regions during the projection period would present opportunities for market expansion.
Amniotic membranes have various uses in treating chronic medical diseases, including kidney injury healing, fetal tissue engineering, and cardiovascular tissue engineering. Stem cell research is receiving increasing financing from the government and several public-private groups, promoting the development of the target industry globally. The major drivers of the expanding acceptance of regenerative medicine and stem cells as well as the rising government initiatives in emerging economies, the presence of a sizable number of stem cell product pipelines, and their usage in regenerative medicine to treat diseases.
By the end of 2050, 25 percent of Saudi Arabia's 40 million inhabitants are expected to be 60 or older. Additionally, it is anticipated that 1.6 million people, or 4% of the population, will be 80 or older by the end of the forecast period. The United Arab Emirates (UAE) healthcare sector is a significant driver of the country’s economic expansion. Due to escalating healthcare prices in western nations and the absence of insurance coverage for particular procedures like dentistry, and orthopedics, the UAE has become a popular choice for westerners seeking medical care. The area’s medical facility is considered the sixth best in the world. This further raises the prospects market players in the regional market.
The Brazil market dominated the LAMEA Amniotic Products Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $23.9 Million by 2030. The Argentina market is estimated to grow at a CAGR of 11.5% during (2023-2030). Additionally, The UAE market would exhibit a CAGR of 10.6% during (2023-2030).
Based on Type, the market is segmented into Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes. Based on Application, the market is segmented into Wound Care, Ophthalmology, Orthopedics, and Others. Based on End-user, the market is segmented into Hospital & Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC
A considerable market expansion for amniotic membranes is anticipated over the forecast period due to increased technological advancements aimed at cost-effective therapies. The growth of the elderly population, increased knowledge of the benefits of amniotic membrane transplantation, and increased amniotic membrane transplantation all contribute to the market's expansion. On the other hand, the enormous market potential in developing regions during the projection period would present opportunities for market expansion.
Amniotic membranes have various uses in treating chronic medical diseases, including kidney injury healing, fetal tissue engineering, and cardiovascular tissue engineering. Stem cell research is receiving increasing financing from the government and several public-private groups, promoting the development of the target industry globally. The major drivers of the expanding acceptance of regenerative medicine and stem cells as well as the rising government initiatives in emerging economies, the presence of a sizable number of stem cell product pipelines, and their usage in regenerative medicine to treat diseases.
By the end of 2050, 25 percent of Saudi Arabia's 40 million inhabitants are expected to be 60 or older. Additionally, it is anticipated that 1.6 million people, or 4% of the population, will be 80 or older by the end of the forecast period. The United Arab Emirates (UAE) healthcare sector is a significant driver of the country’s economic expansion. Due to escalating healthcare prices in western nations and the absence of insurance coverage for particular procedures like dentistry, and orthopedics, the UAE has become a popular choice for westerners seeking medical care. The area’s medical facility is considered the sixth best in the world. This further raises the prospects market players in the regional market.
The Brazil market dominated the LAMEA Amniotic Products Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $23.9 Million by 2030. The Argentina market is estimated to grow at a CAGR of 11.5% during (2023-2030). Additionally, The UAE market would exhibit a CAGR of 10.6% during (2023-2030).
Based on Type, the market is segmented into Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes. Based on Application, the market is segmented into Wound Care, Ophthalmology, Orthopedics, and Others. Based on End-user, the market is segmented into Hospital & Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Organogenesis Holdings, Inc., Amnio technology LLC, Alliqua Biomedical, Inc., Human Regenerative Technologies, LLC (Skye Biologics Holdings Company), Corza Ophthalmology (Corza Medical, Inc.), BioTissue Holdings, Inc., Applied Biologics LLC
Scope of the Study
By Type
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
By Application
- Wound Care
- Ophthalmology
- Orthopedics
- Others
By End-user
- Hospital & Ambulatory Surgical Centers
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- MiMedx Group, Inc.
- Integra LifeSciences Holdings Corporation
- Organogenesis Holdings, Inc.
- Amnio technology LLC
- Alliqua Biomedical, Inc.
- Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
- Corza Ophthalmology (Corza Medical, Inc.)
- BioTissue Holdings, Inc.
- Applied Biologics LLC
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Amniotic Products Market by Type
Chapter 5. LAMEA Amniotic Products Market by Application
Chapter 6. LAMEA Amniotic Products Market by End User
Chapter 7. LAMEA Amniotic Products Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- MiMedx Group, Inc.
- Integra LifeSciences Holdings Corporation
- Organogenesis Holdings, Inc.
- Amnio technology LLC
- Alliqua Biomedical, Inc.
- Human Regenerative Technologies, LLC (Skye Biologics Holdings Company)
- Corza Ophthalmology (Corza Medical, Inc.)
- BioTissue Holdings, Inc.
- Applied Biologics LLC
Methodology
LOADING...
